Cazzola M - Search Results

1

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).

Passamonti F, Cervantes F, Vannucchi AM, Morra E, Rumi E, Pereira A, Guglielmelli P, Pungolino E, Caramella M, Maffioli M, Pascutto C, Lazzarino M, Cazzola M, Tefferi A. Passamonti F, et al. Among authors: cazzola m. Blood. 2010 Mar 4;115(9):1703-8. doi: 10.1182/blood-2009-09-245837. Epub 2009 Dec 14. Blood. 2010. PMID: 20008785 Free article.

2

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.

Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E. Cazzola M, et al. Blood. 1992 Jan 1;79(1):29-37. Blood. 1992. PMID: 1728318 Free article. Clinical Trial.

3

Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia.

Carlo-Stella C, Cazzola M, Gasner A, Barosi G, Dezza L, Meloni F, Pedrazzoli P, Hoelzer D, Ascari E. Carlo-Stella C, et al. Among authors: cazzola m. Blood. 1987 Oct;70(4):1014-9. Blood. 1987. PMID: 3115331 Free article.

4

Natural history of idiopathic refractory sideroblastic anemia.

Cazzola M, Barosi G, Gobbi PG, Invernizzi R, Riccardi A, Ascari E. Cazzola M, et al. Blood. 1988 Feb;71(2):305-12. Blood. 1988. PMID: 3337899 Free article.

5

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.

Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B. Cazzola M, et al. Blood. 1995 Dec 15;86(12):4446-53. Blood. 1995. PMID: 8541533 Free article. Clinical Trial.

6

Translational pathophysiology: a novel molecular mechanism of human disease.

Cazzola M, Skoda RC. Cazzola M, et al. Blood. 2000 Jun 1;95(11):3280-8. Blood. 2000. PMID: 10828006 Free article. Review.

7

Myelodysplastic syndromes: recent advances.

Alessandrino EP, Amadori S, Cazzola M, Locatelli F, Mecucci C, Morra E, Saglio G, Visani G, Tura S. Alessandrino EP, et al. Among authors: cazzola m. Haematologica. 2001 Nov;86(11):1124-57. Haematologica. 2001. PMID: 11694400 Review. No abstract available.

8

A novel deletion of the L-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome.

Cazzola M, Foglieni B, Bergamaschi G, Levi S, Lazzarino M, Arosio P. Cazzola M, et al. Br J Haematol. 2002 Mar;116(3):667-70. doi: 10.1046/j.0007-1048.2001.03310.x. Br J Haematol. 2002. PMID: 11849230 Free article.

9

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.

Passamonti F, Malabarba L, Orlandi E, Pascutto C, Brusamolino E, Astori C, Baratè C, Canevari A, Corso A, Bernasconi P, Cazzola M, Lazzarino M. Passamonti F, et al. Among authors: cazzola m. Br J Haematol. 2002 Mar;116(4):855-61. doi: 10.1046/j.0007-1048.2002.03367.x. Br J Haematol. 2002. PMID: 11886392 Free article.

10

Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.

Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, Arosio P. Cazzola M, et al. Blood. 2003 Mar 1;101(5):1996-2000. doi: 10.1182/blood-2002-07-2006. Epub 2002 Oct 24. Blood. 2003. PMID: 12406866 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,246 results

Search Page

Filters